广泛的动脉静脉囊血栓与像葡萄糖一样的-1激动剂
Muhammad Muneeb1, Elizabeth Choi2, Coralys Rodriguez3
1Internal Medicine, Trinity Health Oakland/Wayne State University, Pontiac, USA.
Cureus
|August 18, 2025
概括
葡萄糖类-1 (GLP-1) 受体激动剂虽然有益,但很少会导致严重的血栓事件. 这一案例突出显示了一例罕见的GLP-1激动剂诱导的血栓在脏移植患者.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
背景情况:
- 葡萄糖类-1 (GLP-1) 受体激动剂已被确立为心血管和的益处.
- 潜在的不良影响,包括血栓性并发症,需要仔细考虑.
研究的目的:
- 报告一种罕见的GLP-1受体激动剂诱导的血栓性并发症.
- 为了为关于这种不良影响的有限文献做出贡献.
主要方法:
- 一个中年非洲裔美国女性的病例报告,接受了移植.
- 临床表现,体检和多普勒超声波的发现.
- 排除其他前血栓性原因.
主要成果:
- 动脉静脉 (AV) 囊,臂脑静脉和上肢动脉的广泛血栓形成.
- 血栓形成暂时与GLP-1受体激动剂剂量升级相关.
- 没有显著的前血栓检查.
结论:
- GLP-1受体激动剂被认为是血栓事件的原因.
- 停用GLP-1受体激动剂导致没有进一步的血栓事件.
- 突出了常用药物的罕见,危及生命的副作用的潜力.
相关概念视频
Glucagon-like Receptor Agonists
416
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
416
Hemodialysis I: Introduction
287
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
287
Hypoglycemia and Glucagon
334
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
334
Peripheral Artery Disease V: Postoperative Nursing Management
25
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
25
Dipeptidyl Peptidase 4 Inhibitors
256
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
256
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.4K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.4K


